Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study.
Saved in:
| Title: | Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study. |
|---|---|
| Authors: | Mao-Draayer Y; Autoimmunity Center of Excellence, Multiple Sclerosis Center, University of Michigan, Ann Arbor, MI, USA., Cohen JA; Mellen Center, Cleveland Clinic, Cleveland, OH, USA., Bar-Or A; Center for Neuroinflammation and Experimental Therapeutics, and the Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Han MH; Department of Neurology, Stanford University, Stanford, CA, USA., Singer B; Missouri Baptist Medical Center, St Louis, MO, USA., Williams IM; Oxford PharmaGenesis Ltd, Oxford, UK., Meng X, Elam C, Weiss JL, Cox GM, Ziehn M; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Cree BA; UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. |
| Corporate Authors: | FLUENT study investigators |
| Source: | Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2022 Aug 01; Vol. 8 (3), pp. 20552173221115023. Date of Electronic Publication: 2022 Aug 01 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Ltd Country of Publication: United States NLM ID: 101668877 Publication Model: eCollection Cited Medium: Print ISSN: 2055-2173 (Print) Linking ISSN: 20552173 NLM ISO Abbreviation: Mult Scler J Exp Transl Clin Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2055-2173 |
|---|---|
| DOI: | 10.1177/20552173221115023 |
